Carmell Therapeutics Corporation Class A Common Stock Gains 140.06%
Thu, Jan 02, 2025 at 07:08 PM
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ) soared at $0.69, a gain of 140.1%. On Thu, Jan 02, 2025, CTCX:NASDAQ hit a New 2-Week High of $0.69. The stock appeared on our News Catalysts scanner on Thu, Jan 02, 2025 at 10:18 AM in the 'AGREEMENT' category. From Thu, Dec 19, 2024, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Thu, Jan 02, 2025 at $1.2 with a volume of 313M+.
About Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ)
Alpha Healthcare Acquisition Corp III is a blank check company.
Top 10 Gainers:
- N2OFF Inc. (NITO:NASDAQ), 331.45%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 140.06%
- Smart for Life Inc. (SMFL:NASDAQ), 132.18%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 82.54%
- Crown LNG Holdings Limited (CGBS:NASDAQ), 69.48%
- SuperCom Ltd. (SPCB:NASDAQ), 59.34%
- Quantum-Si Incorporated (QSI:NASDAQ), 57.78%
- Heartcore Enterprises Inc. (HTCR:NASDAQ), 56.47%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 51.85%
- Passage Bio, Inc. (PASG:NASDAQ), 46.36%